Beyond Statin Intolerance: Applying the New Dyslipidemia Guidelines to Achieve LDL-C Goals

This program will provide practical guidance on recognizing and managing statin intolerance, including distinguishing true intolerance from statin-associated symptoms and establishing a maximally tolerated statin regimen. Faculty will review how to apply the 2026 ACC/AHA/Multi-society Dyslipidemia Guideline to identify LDL-C treatment gaps and select evidence-based non-statin therapies to help patients safely achieve their LDL-C goals.

Lecturer

Ijeoma Isiadinso, MD, MPH, FACC, FASNC, is a Preventative Cardiologist and Associate Professor of Medicine with the Division of Cardiology at Emory University School of Medicine. She is the Medical Director of the Emory Center for Heart Disease Prevention. Dr. Isiadinso earned a dual degree in Medicine and Public Health during medical school. She completed her Internal Medicine Residency and Cardiology Fellowship at Temple University Hospital where she also served as Chief Fellow in her final year. She is Board Certified in General Cardiology, Nuclear Cardiology, Echocardiography.

Dr. Isiadinso is a dedicated clinician and researcher. She was a member of the writing group for the 2025 ACC/AHA Guideline on the Management of Patients with Acute Coronary Syndromes. She is committed to cardiovascular disease prevention. In 2013, she was recognized as an American Heart Association Power to End Stroke Ambassador for her efforts to increase stroke awareness in the African-American community. For several years, Dr. Isiadinso has been recognized as a Castle Connolly Atlanta “Top Doctor”. She has also received the Castle Connolly Exceptional Women in Medicine Award annually since 2020.  She is passionate about preventing heart disease with special clinical interests in the management of complex lipid disorders, cardiovascular disease in women and cardiovascular risk reduction in patients with systemic inflammatory conditions.

Moderator

Ramzi Dudum, MD, MPH, FASPC, is a cardiologist dedicated to caring for patients with cardiovascular disease and those at risk, with a strong focus on prevention. He works closely with patients to develop personalized care plans that align with their values while effectively addressing risk.

Dr. Dudum earned his medical degree from The George Washington University and completed his internal medicine residency at Johns Hopkins Hospital, where he also received a Master of Public Health. He then trained in cardiovascular medicine at Stanford Medicine, followed by the Stanford/Intermountain fellowship in population health, delivery science, and primary care.

His research leverages his expertise in population health to design systems and pathways that improve cardiovascular outcomes and longevity. He is particularly interested in advancing personalized risk prediction for heart disease and collaborates with experts in artificial intelligence (AI) and implementation science to develop best practices for integrating AI into healthcare and research.

Within the American Society for Preventive Cardiology (ASPC), Dr. Dudum serves as Co-Chair of the Fellows-in-Training and Early Career Interest Group. In this role, he helps lead the group’s mission: to foster support, mentorship, and camaraderie among trainees and early career physicians passionate about the prevention of cardiovascular disease.

Support for this program provided by: